BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

Biosante has very educated people in their camp. They must have a reason for doing it.

Possibilities include:

Susbset analysis of Bloom trials showed something promising and meetings with FDA are working on another more restrictive trial singling out the target audience to prove efficacy.

FDA is requesting something to have Testosterone delivery and CV reduction included or the primary purpose of Libigel.

Decision to take Libigel to NDA application rather then look to have a partner take over.

To fund a phase 3 cancer trial.

To fund the Pill Plus phase III trials

Prepare the company for a sale

I am certain there are other possibilities and that it will all make sense when the information is released.